Flex

2K posts

Flex banner
Flex

Flex

@Medrobotics

Medrobotics Flex® Robotic System is a commercial, endoluminal robotic platform with a steerable and shapeable robotic scope. #MedTech innovation & #robotics.

Raynham, MA Katılım Haziran 2017
3.1K Takip Edilen1.5K Takipçiler
Flex
Flex@Medrobotics·
The FDA has approved the first augmented reality headset designed for surgical guidance. The device gives surgeons “x-ray vision” during procedures, according to its developers. medcitynews.com/2019/12/fda-ap…
English
0
1
4
0
Flex retweetledi
FierceBiotech
FierceBiotech@FierceBiotech·
After a series of tests, Angers and colleagues confirmed that IPO11 is required for beta-catenin nuclear import. Specifically, Importin-11 binds to beta-catenin and guides it into the cell nucleus of colorectal cancer cells with APC mutations fiercebiotech.com/research/how-a…
English
0
3
9
0
Flex
Flex@Medrobotics·
A team of researchers exploring ways to improve human-robot interaction found that people may trust robots more if the bot can communicate what it’s doing. techxplore.com/news/2019-12-r… #Robotics
English
0
0
0
0
Flex retweetledi
STAT
STAT@statnews·
Opinion: In developing cancer drugs, the focus has been on eradicating cancer cells and shrinking tumors. It's time to also focus on patient factors like tolerability, ease of use, compliance with the therapy, and quality of life. buff.ly/2EPUUBg
English
2
32
72
0
Flex
Flex@Medrobotics·
Happy Holidays!
Flex tweet media
English
0
0
0
0
Flex
Flex@Medrobotics·
If you want to be part of a team with like-minded people working together to achieve a shared vision, then we want to hear from you. #Clinical%20/%20Regulatory%20Affairs" target="_blank" rel="nofollow noopener">medrobotics.com/about/careers/… #Robotics #MedTech #HealthCareers
Flex tweet media
English
0
0
1
0
Flex retweetledi
Charles Reed Anderson
Charles Reed Anderson@CRAAmsterdam·
Nearly 80% of Chinese hospitals either plan to, or have already carried out, medical AI apps. Tencent's AI Medical Imaging screens for cancer & has an accuracy rate of 90% for esophageal cancer, 97% for diabetic retinopathy, & 97.2% for colorectal cancer buff.ly/374EiBT
English
0
2
1
0